Target intelligence / Profile preview

Ubiquitin specific protease 11 (USP11)

Target
USP11
Molecular classification
Enzyme, Deubiquitinase, Cysteine protease, Chromatin modifier
01

Overview

Ubiquitin specific protease 11 (USP11) is a cysteine protease enzyme that functions as a deubiquitinase, specifically removing ubiquitin from proteins to regulate their stability, localization, and activity[1][2][3][4]. USP11 is involved in key cellular processes including DNA damage repair, cell cycle control, and chromatin remodeling by deubiquitinating target proteins such as histone H2A, histone H2B, BRCA2, PALB2, p21, and XPC[3][4]. It plays a pivotal role in genomic stability, cell survival, and response to genotoxic stress. Dysregulation or overexpression of USP11 has been implicated in several cancers, where it may promote tumor progression or serve as a prognostic biomarker, especially in ERα-positive breast cancer[5]. USP11 is therefore considered a promising therapeutic target in oncology and potentially other diseases involving altered protein ubiquitination[4].

Other names
ubiquitin-specific protease 11ubiquitin specific peptidase 11
02

Mechanism of action

Inhibition of deubiquitinase activity leads to impaired DNA repair and altered cell proliferation

03

Biological functions

DNA repairHistone deubiquitinationChromatin remodelingCell cycle regulationCell survivalGenomic stabilityTranscriptional regulation
04

Disease associations

CancerNeurodegenerationInfection
05

Safety considerations

Potential for genomic instability or impaired DNA repair as an on-target toxicity
06

Biomarkers

High USP11 expression as a potential prognostic marker in ERα-positive breast cancer[5]

Beyond the preview

Go deeper on Ubiquitin specific protease 11 (USP11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin specific protease 11 (USP11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call